Stemmatters is committed to supporting the development and translation of pioneering therapeutic drug candidates and non-clinical biological products. Leveraging over a decade of experience in developing both proprietary assets and those of our valued partners, Stemmatters has a rich history of successful R&D over a range of technology domains.
Based in the Braga district, just north of Porto, we are embedded in a rich local and national network of research and development centres and clinical facilities. Our location affords convenient access to Porto International Airport (OPO), which services flights throughout Europe and across the Atlantic.
Stemmmatters was created in 2007 as an academic spin-off of University of Minho, Portugal. The company has since generated substantial know-how and experience regarding the development and manufacturing of a diverse set of regenerative medicine products across several technology domain verticals. The track-record of the company has resulted in the development and consolidation of a highly differentiated biomaterial product platform, currently being exploited for multiple indications. Stemmatters has acquired significant experience and track record in developing and manufacturing medical devices and medicinal products, including biopharmaceuticals, which is sustained by a successful track-record of multiple site audits and authorizations from business partners and competent authorities.